EpiVax Inc - Strategic SWOT Analysis Review

EpiVax Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope


- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy –  summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

EpiVax Inc (EpiVax) develops analytical capabilities in the field of computational immunology. Its product pipeline includes Tregitopes; deimmunization projects including deimmunized botox and deimmunized FVIII; and biodefense vaccines. Tregitopes are linear sequences of amino acids which activate natural regulatory T cells. It is an immune-modulation power tool which is being developed for auto-immune, auto-inflammatory and allergic conditions. EpiVax’ service portfolio includes, immune engineering, immunogenicity screening, vaccine design and redesign. It also provides lab services such as in vivo, in vitro and ex vivo immunogenicity screening services including cell-free HLA binding assays. EpiVax is headquartered in Providence, Rhode Island, the US.

EpiVax Inc Key Recent Developments

Mar 06,2020: EpiVax partners with UGA researcher on Covid-19 vaccine
Dec 23,2019: EpiVax announces record year for growth in 2019 and sets new milestones for 2020
Dec 20,2019: On eve of new decade, EpiVax re-pledges commitment to improving health everywhere

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with  detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.
 


Section 1 - About the Company
EpiVax Inc - Key Facts
EpiVax Inc - Key Employees
EpiVax Inc - Key Employee Biographies
EpiVax Inc - Key Operational Employees
EpiVax Inc - Major Products and Services
EpiVax Inc - History
EpiVax Inc - Company Statement
EpiVax Inc - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
EpiVax Inc - Business Description
EpiVax Inc - SWOT Analysis
SWOT Analysis - Overview
EpiVax Inc - Strengths
EpiVax Inc - Weaknesses
EpiVax Inc - Opportunities
EpiVax Inc - Threats
EpiVax Inc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
EpiVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
EpiVax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
EpiVax Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 06, 2020: EpiVax partners with UGA researcher on Covid-19 vaccine
Dec 23, 2019: EpiVax announces record year for growth in 2019 and sets new milestones for 2020
Dec 20, 2019: On eve of new decade, EpiVax re-pledges commitment to improving health everywhere
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


EpiVax Inc, Key Facts
EpiVax Inc, Key Employees
EpiVax Inc, Key Employee Biographies
EpiVax Inc, Key Operational Employees
EpiVax Inc, Major Products and Services
EpiVax Inc, History
EpiVax Inc, Key Competitors
EpiVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
EpiVax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
EpiVax Inc, Recent Deals Summary


List Of Figures


EpiVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
EpiVax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


Binx Health Inc - Product Pipeline Analysis, 2021 Update

Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for womens health. The company develops its

USD 750 View Report

Profound Medical Inc - Product Pipeline Analysis, 2021 Update

Profound Medical Inc (Profound Medical) is a medical device company that develops and markets solutions to deliver precise ablation of prostate. Its proprietary technology, TULSA-PRO, by combining real-time magnetic resonance

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available